-
Zanubrutinib in Bing Neel syndrome: efficacy and tolerability: LYMPHOMA
Becking, A.-M. L., van de Mortel, J. P. M., Tomkins, O., Flinsenberg, T. W. H., Japzon, N., Kersten, M. J., Khwaja, J., Kuipers, S., Levenga, H., McKeague, S., Opat, S., Salvaris, R. T., Seif, S., Thomas, S. K., Vrancken, A. F. J. E., D’Sa, S., Minnema, M. C. & Vos, J. M. I., May 2025, In: Leukemia. 39, 5, p. 1260-1264 5 p., e155.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Report of consensus panel 2 from the 12th international workshop on the management of Bing-Neel syndrome in patients with Waldenstrom's Macroglobulinemia
Sarosiek, S., Becking, A.-M. L., Branagan, A., Ferrero, S., Khwaja, J., Kimby, E., Roos-Weil, D., Sekiguchi, N., Trneny, M., Yi, S., Patterson, C. J., Buske, C., Matous, J. V., Treon, S. P. & Minnema, M. C., Apr 2025, In: Seminars in hematology. 62, 2, p. 85-89 5 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study
Guman, N. A. M., Becking, A.-M. L., Weijers, S. S., Kraaijpoel, N., Mulder, F. I., Carrier, M., Jara-Palomares, L., Di Nisio, M., Ageno, W., Beyer-Westendorf, J., Klok, F. A., Vanassche, T., Otten, J. M. M. B., Cosmi, B., Peters, M. J. L., Wolde, M. T., Delluc, A., Sanchez-Lopez, V., Porreca, E. & Bossuyt, P. M. M. & 4 others, , Sept 2024, In: Journal of thrombosis and haemostasis : JTH. 22, 9, p. 2470-2481 12 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
